Dr. Ronney Abaza Joins Central Ohio Urology Group

COLUMBUS, Ohio–(BUSINESS WIRE)–Central Ohio Urology Group is pleased to announce that Ronney Abaza, MD, FACS, one of the most experienced robotic surgeons in the world, has joined the group to continue his focus on robotic surgery for prostate, kidney and bladder cancers and other urological conditions. Dr. Abaza ranks in the top five internationally for robotic surgery volume with more than 6,000 procedures performed, as well as being the first in the world to perform several robotic procedures.

With a clinical network of 15 offices, Central Ohio Urology Group is the region’s leading provider of comprehensive urological services, including general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Facilities in the Columbus area include an Advanced Prostate Cancer Clinic, as well as a state-of-the-art, urology-specific ambulatory surgery center. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital.

Mark Cherney, CEO of Central Ohio Urology Group and U.S. Urology Partners, stated, “We are honored that Dr. Ronney Abaza has joined the team at Central Ohio Urology Group. As an internationally recognized pioneer in robotic surgery, he will make tremendous contributions as a member of our clinical team and, most importantly, to our patients.”

Ronney Abaza, MD, FACS, said, “Having practiced in Central Ohio for nearly 15 years, I was already aware of the excellence of the urologists at Central Ohio Urology Group, but I’m most excited to join the group because of their forward-thinking vision for robotic surgery. Central Ohio Urology Group will have one of the first urology-specific ambulatory surgery centers in the country to offer patients robotic surgery. I couldn’t pass up the opportunity to help shape this program and create the best possible experience for our patients tailored just to them and what they need.”

“My practice is 99% robotic surgery for prostate, kidney, bladder and other urologic cancers, and most of the surgeries I perform are on an outpatient basis. It was Central Ohio Urology Group’s commitment to advanced technologies, and specifically an investment in a robot, that created this opportunity. Given that ambulatory surgery center operating costs are much lower than a typical hospital, we can offer a cost-effective solution. I will continue to perform robotic surgeries in area hospitals as well, but most of my patients will now be able to have their cancer surgeries without ever having to stay in a hospital and will be back home with their family around them the same day as their surgery,” added Dr. Abaza.

Dr. Abaza is now accepting patients and will primarily serve them in the Dublin and Gahanna offices. To learn more about Dr. Abaza, visit www.centralohiourology.com or www.drabaza.com. For additional information or to schedule an appointment or refer a patient to Dr. Abaza, please contact (614) 796-2842 or request an appointment at www.centralohiourology.com.

About Central Ohio Urology Group

Central Ohio Urology Group is one of the nation’s leading providers of urological services with a network of 15 offices in the region. Headquartered just outside of Columbus in Gahanna, Ohio, Central Ohio Urology Group provides comprehensive services, including general urology, men’s health, women’s health, cancer care, advanced cancer treatment and radiation oncology. Facilities in the Columbus area include an Advanced Prostate Cancer Clinic, as well as a state-of-the-art, urology-specific ambulatory surgery center that is one of the first in the country to offer robotic surgery. Central Ohio Urology Group’s experienced care team provides more than 50 urological specialties and subspecialties. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.centralohiourology.com and www.us-uro.com.

Contacts